Molnupiravir, also known by its brand name MK-4488, represents a significant advancement in the fight against the pandemic. This oral antiviral medicine works by introducing errors into the SARS-CoV-2's genetic code, effectively preventing its duplication and spread within the patient. While initial data suggested a considerable reduction in hospit